Clinical Research Directory
Browse clinical research sites, groups, and studies.
Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation
Sponsor: Oulu University Hospital
Summary
The goal of this clinical trial is to investigate the differences in microbiota, height and weight between infants born by cesarean section and randomized to receive fecal microbiota transplant after birth. The main questions it aims to answer are: * Could micobiota transplant be used improve gut microbiota and prevent overweight or obesity. * Is the source of colonization a modifiable factor and can it be changed by using an early fecal microbiota transplant.
Official title: Section-Born Infants and SUccessful Health Outcomes After Fecal Microbiota Transplantation (SISU-FMT)
Key Details
Gender
FEMALE
Age Range
18 Years - 49 Years
Study Type
INTERVENTIONAL
Enrollment
534
Start Date
2026-03-31
Completion Date
2036-12-31
Last Updated
2026-04-07
Healthy Volunteers
No
Interventions
Microbiota transplant from mother
At delivery, the microbiota transplant is thawed and 0.5 mL representing 3.5 mg of the mother's or donors' fecal sample is dissolved in 5 mL of the mother's own milk or when not available pasteurized bank milk. The sample is given orally to newborn infants as soon as possible but not later than 6 h of delivery and not later than two hours after defrosting.
Locations (1)
Oulu University Hospital
Oulu, Finland